HYOGO COLLEGE OF MEDICINE;MITSUBISHI TANABE PHARMA CORPORATION
发明人:
YOSHIMOTO, Tomohiro,PALUMBO, Joseph M.,STONE, I. Violetta,KATO, Toru,YASUDA, Koubun
申请号：
SG11202001786P
公开号：
SG11202001786PA
申请日:
2018.08.31
申请国别(地区):
SG
年份:
2020
代理人:
摘要：
To provide a therapeutic agent for endometriosis and adenomyosis. IL-33 was identified as an exacerbating factor in endometriosis and adenomyosis, and an IL-33 antagonist, which is capable of inhibiting the function of IL-33, was found to be useful for treating, preventing or alleviating endometriosis and uterine adenomyosis.
